GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Market Closed 05-17 16:00:00 EDT

22.39

-1.63

-6.79%

盘后23.03

+0.64+2.86%

19:45 EDT

High24.40	Low22.27	Vol345.68K
Open23.85	D1 Closing24.02	Amplitude8.87%
Mkt Cap585.52M	Tradable Cap360.38M	Total Shares26.15M
T/O7.99M	T/O Rate2.15%	Tradable Shares16.10M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":22.39,"timestamp":1715976000000,"preClose":24.02,"halted":0,"volume":345675,"hourTrading":{"tag":"盘后","latestPrice":23.03,"preClose":22.39,"latestTime":"19:45 EDT","volume":642,"amount":14469.15,"timestamp":1715989513150},"delay":0,"floatShares":16095389,"shares":26150866,"eps":-5.230775,"marketStatus":"Market Closed","change":-1.63,"latestTime":"05-17 16:00:00 EDT","open":23.85,"high":24.4,"low":22.27,"amount":7991097.911775,"amplitude":0.088676,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.230775,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":24.02,"preHourTrading":{"tag":"盘前","latestPrice":23.9,"preClose":24.02,"latestTime":"09:12 EDT","volume":821,"amount":19582.939445,"timestamp":1715951533384},"postHourTrading":{"tag":"盘后","latestPrice":23.03,"preClose":22.39,"latestTime":"19:45 EDT","volume":642,"amount":14469.15,"timestamp":1715989513150},"volumeRatio":0.44533616839227713},"requestUrl":"/m/hq/s/WGS","defaultTab":"news","newsList":[{"id":"2432587478","title":"Sector Update: Health Care Stocks Mixed Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2432587478","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2432587478?lang=en_us&edition=fundamental","pubTime":"2024-05-01 03:58","pubTimestamp":1714507105,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed late Tuesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund  little changed, erasing earlier gains.In corporate news, the Federal Trade Commission sent warning letters to 10 companies and notified the Food and Drug Administration that it disputes the accuracy or relevance of more than 300 patent listings across 20 different brand name products in the FDA's Orange Book. The FTC's challenges include patent listings for Novo Nordisk's  Ozempic, Victoza, and Saxenda. Novo Nordisk shares rose 1.2%.GeneDx  reported late Monday that its Q1 adjusted net loss narrowed following a surge in revenue. TD Cowen adjusted the company's price target to $24 from $14 while keeping its buy rating. Its shares surged almost 60%.Eli Lilly  lifted its full-year outlook after delivering higher Q1 results on a yearly basis, boosted by sales of the company's Mounjaro diabetes drug and weight-loss drug Zepbound. Its shares jumped 6%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sector-health-care-stocks-mixed-195825624.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432836301","title":"BKKT, CETX and SWVL among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2432836301","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2432836301?lang=en_us&edition=fundamental","pubTime":"2024-05-01 01:43","pubTimestamp":1714498980,"startTime":"0","endTime":"0","summary":"Gainers: GeneDx Holdings Corp  +47%. Cyclacel Pharmaceuticals  +47%. Swvl Holdings Corp  +38%. Eliem Therapeutics  +36%. Haoxi Health Technology Ltd.  +37%. AGBA Group Holding Limited  +31%. LendingTree  +28%. MIND Technology  +28%. SES AI Corporation  +22%.  Marin Software  +17%.  Losers: Cemtrex  -30%. Lichen China Ltd  -30%. Chegg  -27%. NRX Pharmaceuticals  -25%. Bakkt Holdings  -23%. Medifast  -22%. Annovis Bio  -18%. H&E Equipment Services  -18%. Microstrategy  -17%. Top Wealth Group Holding Limited  -17%.","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4096652-bkkt-cetx-and-swvl-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431932152","title":"Annovis Bio, Cyclacel Pharmaceuticals, Biodexa Pharmaceuticals among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431932152","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431932152?lang=en_us&edition=fundamental","pubTime":"2024-04-30 22:01","pubTimestamp":1714485667,"startTime":"0","endTime":"0","summary":"Gainers: Cyclacel Pharmaceuticals  +35%. GeneDx Holdings  +31%. Eliem Therapeutics  +18%. JanOne  +13%. Harmony Biosciences Holdings  +15%.  Losers: NRX Pharmaceuticals  -26%. NewGenIvf Group  -12%. Annovis Bio  -12%. GE HealthCare Technologies  -9%. Biodexa Pharmaceuticals Plc ADR  -11%.   S&P 500 Health Care Sector +0.45% to 1643.55. Health Care Equipment & Services -0.37% to 1921.91. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.73% to 1334.8.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4096292-annovis-bio-cyclacel-pharmaceuticals-biodexa-pharmaceuticals-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431734289","title":"NKTR, IMNM and MAIA are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431734289","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431734289?lang=en_us&edition=fundamental","pubTime":"2024-04-30 20:42","pubTimestamp":1714480935,"startTime":"0","endTime":"0","summary":"Gainers: Cyclacel Pharmaceuticals Inc (CYCC) +60% FORM 10-K/A | Amended Annual Report.  Auddia Inc (AUUD) +34% Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natura","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4096200-nktr-imnm-and-maia-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431752343","title":"GeneDx Holdings Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2431752343","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2431752343?lang=en_us&edition=fundamental","pubTime":"2024-04-30 19:54","pubTimestamp":1714478040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2024 07:54 ET (11:54 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2431807388","title":"GeneDx Holdings Corp reports results for the quarter ended in January - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2431807388","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2431807388?lang=en_us&edition=fundamental","pubTime":"2024-04-30 09:46","pubTimestamp":1714441590,"startTime":"0","endTime":"0","summary":"* GeneDx Holdings Corp    reported a quarterly adjusted loss of 33 cents per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $-2.44.  T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431287249","title":"GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2431287249","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2431287249?lang=en_us&edition=fundamental","pubTime":"2024-04-30 05:50","pubTimestamp":1714427404,"startTime":"0","endTime":"0","summary":"GeneDx Holdings Corp.  came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to loss of $2.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 51.47%. A quarter ago, it was expected that this company would post a loss of $0.60 per share when it actually produced a loss of $0.59, delivering a surprise of 1.67%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.GENEDX HOLDINGS , which belongs to the Zacks Medical Services industry, posted revenues of $62.42 million for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 25.35%. This compares to year-ago revenues of $43.14 million. The company has topped consensus revenue estimates three times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the perform","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genedx-holdings-corp-wgs-reports-215004621.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431260208","title":"GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2431260208","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2431260208?lang=en_us&edition=fundamental","pubTime":"2024-04-30 05:14","pubTimestamp":1714425242,"startTime":"0","endTime":"0","summary":"GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million by 26.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38505448/genedx-stock-climbs-after-better-than-expected-q1-results-raises-fy24-guidance","is_publish_highlight":false,"gpt_icon":0},{"id":"2431825496","title":"RMBS, SANM and WGS are among after hour movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2431825496","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431825496?lang=en_us&edition=fundamental","pubTime":"2024-04-30 05:00","pubTimestamp":1714424421,"startTime":"0","endTime":"0","summary":"Gainers: GeneDx Holdings  (WGS) +22%.\nZapp Electric Vehicles Group  (ZAPP) +8%.\nAmkor Technology (AMKR) +7%.\nWoodward (WWD) +6%.\nNXP Semiconductors (NXPI) +5%.\n\nLosers: F5 (FFIV) -11%.\nSanmina Corporation (SANM) -6%.\nInozyme Pharma (INZY) -5%.\nEton Pharmaceuticals (ETON) -5%.\nRambus (RMBS) -4%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095908-rmbs-sanm-and-wgs-are-among-after-hour-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2431823423","title":"GeneDx Hldgs Q1 2024 Adj EPS $(0.33) Beats $(0.67) Estimate, Sales $62.422M Beat $49.463M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2431823423","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2431823423?lang=en_us&edition=fundamental","pubTime":"2024-04-30 04:48","pubTimestamp":1714423696,"startTime":"0","endTime":"0","summary":"GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.67) by 50.75 percent.  The company reported quarterly sales of $62.422 million which beat the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38504527/genedx-hldgs-q1-2024-adj-eps-0-33-beats-0-67-estimate-sales-62-422m-beat-49-463m-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2431013879","title":"GeneDx Q1 2024 Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2431013879","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431013879?lang=en_us&edition=fundamental","pubTime":"2024-04-29 05:35","pubTimestamp":1714340100,"startTime":"0","endTime":"0","summary":"GeneDx  is scheduled to announce Q1 earnings results on Monday, April 29th, after market close.The consensus EPS Estimate is -$0.67  and the consensus Revenue Estimate is $49.45M .Over the last 3 months, EPS estimates have seen 1 upward revision and 2 downward. Revenue estimates have seen 3 upward revisions  and 1 downward.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4094997-genedx-q1-2024-earnings-preview","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":0.079},{"period":"1month","weight":1.4337},{"period":"3month","weight":3.4337},{"period":"6month","weight":12.9937},{"period":"1year","weight":2.7008},{"period":"ytd","weight":7.1418}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.22757},{"month":2,"riseRate":1,"avgChangeRate":0.478474},{"month":3,"riseRate":0.25,"avgChangeRate":-0.131493},{"month":4,"riseRate":0.25,"avgChangeRate":0.057396},{"month":5,"riseRate":0.25,"avgChangeRate":0.006926},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.161055},{"month":7,"riseRate":0.666667,"avgChangeRate":0.111381},{"month":8,"riseRate":0,"avgChangeRate":-0.30921},{"month":9,"riseRate":0,"avgChangeRate":-0.17426},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.083994},{"month":11,"riseRate":0,"avgChangeRate":-0.276829},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011354}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction